Research programme: infectious disease therapeutics - Fraunhofer Institute for Molecular Biology and Applied Ecology/SanofiAlternative Names: Infectious disease therapeutics - Fraunhofer IME/Sanofi
Latest Information Update: 24 Jan 2014
At a glance
- Originator Fraunhofer Institute for Molecular Biology and Applied Ecology; Sanofi
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Research Infections
Most Recent Events
- 15 Jan 2014 Early research in Infections in Germany (unspecified route)
- 15 Jan 2014 Early research in Infections in France (unspecified route)